The newest pharmaceutical factory is based in Sofia under the name of Fortex. The investment is to the amount of BGN 3 million.The company- Fortex Nutraceuticals has recently traded solely with nutritional supplements, but now it handed out papers for registration of drug and medical goods in the BDA and expects to produce them in the new factory. It is to start operation in April in the Sofia neighbourhood Suhodol. 35 types of capsules and sachets will be manufactured there, aimed both for the domstic market and for export in ten other countries. The company started opearation 10 years ago in an office. At present Fortex has a line of 40 supplements-capsules, tablets, syrups, gels, etc. For the past ten years the company has not had its own capacity and relied on execution of orders by other manufactureres. Three Bulgarian pharmaceutical plants produce supllements for Fortex. These are namely- Adipharm, pharmaceutical plants Milve, Lavena - Shoumen.
Source: Capital (20.02.2013)

Lavena AD is to look for BGN 2.67 million from the market. If the increase of capital is successful it is to grow from BGN 200 thousand to BGN 266 667. Trade with rights that allow participation in the capital increase will be launched on April 23, 2013. He deadline for trade on the stock exhange is the 30th of April. The increase of capital will be made via BenchMarck Finance AD
Source: profit.bg (15.04.2013)

Bulgarian cosmetics manufacturers export more than 75% of their production Bulgarian cosmetics manufacturers export more than 75 percent of their production abroad, according to the Bulgarian National Association for Essential Oils, Perfumery and Cosmetics. Chances to expand overseas sales we see in the face of Africa and the Middle East. Overall, when compared with other companies in the country, sales of cosmetics companies in Bulgaria are 5.3 times more profitable than others, passed "Standard." According to the Bulgarian Chamber of overall liquidity is higher by 45.2%. The debt ratio is 3.1 times less than the average for the Bulgarian economy. The sector seems to be much more stable than others and hold their positions in the market. This happens even though market indicators have worsened due to the global financial and economic crisis. Bulgaria exported so many cosmetics because our market is very small, but it is open to different foreign cosmetic brands and companies.(inews.bg)
Source: Other (30.04.2013)

Lavena AD reported a profit to the amount of BGN 120 thousand in its consolidated report for the first quarter of the year. Total revenues are to the amount of BGN 1 966 thousand, which is an increase of 9.71%, as compared to previous quarter. Total expenditures registered increase of 13.25% up to BGN 1846 thousand. Net sales revenues in the end of March are to the amount of BGN 1954 thousand and represent 99.39 % of total revenues. As compared to previous period they have gone up by 9.28%. The company’s equity capital is to the amount of BGN 2957 thousnad, which as compared to last year increased by 31.54%.
Source: money.bg (13.06.2013)

Bulgarian lavender oil and cosmetics producer Lavena is planning to build a new factory in the northeastern town of Shumen. The decision should be approved by Lavena shareholders at a general meeting, to be held on September 23. The construction of the new factory is estimated at BGN 6.8 million. The project will be completed within a period of over 12 months. The company disposes with enough equities to finance by itself the project, including the order of machinery. The path towards modernization is inevitable for the company, which reports stable revenues from sales on the local market and is getting orders from foreign customers, as well. One of the last projects of Lavena is focused on foreign customers and is a cosmetic line called My Rose of Bulgaria. It includes hydrating creams, shampooes, soaps and perfumes with rose aroma. At present Lavena is selling in countries from the EU, Russia, and Lebanon while in the midterm the company is oriented towards the Balkans, the Arab countries and Asia.
Source: Capital (23.08.2013)